BioCentury
ARTICLE | Company News

Pfizer, Catholic University Leuven deal

September 27, 2010 7:00 AM UTC

The university granted Pfizer exclusive, worldwide rights to develop and commercialize ledgins to treat HIV infection. Ledgins are compounds which inhibit the interaction between viral integrase and t...